HGWM
VNDA icon

Harvest Group Wealth Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Harvest Group Wealth Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-86
Closed -$1K – 1022
2019
Q4 		$1K Hold
86
– – ﹤0.01% 889
2019
Q3 		$1K Buy
+86
New +$1.2K ﹤0.01% 942

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Harvest Group Wealth Management's VNDA Position: Q1 2020 in Review

Harvest Group Wealth Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 86 shares — an estimated $1K sold.

Harvest Group Wealth Management first reported a position in VNDA in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

  • Harvest Group Wealth Management reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Harvest Group Wealth Management sold 86 Vanda Pharmaceuticals shares in Q1 2020, an estimated $1K.
  • Harvest Group Wealth Management first reported a position in Vanda Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Harvest Group Wealth Management's Vanda Pharmaceuticals position peaked at $1K in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Harvest Group Wealth Management's 13F filing for Q1 2020, filed 23 Apr 2020.